Amir Horowitz: Treatment strategies and management of BCG-unresponsive NMIBC
Amir Horowitz shared on X:
“Honored to play small role in shaping guidelines for treatment strategies and management of BCG-unresponsive NMIBC under the brilliant efforts of Ashish M. Kamat and IBCG.”
Source: Amir Horowitz/X
Authors: Roger Li, Patrick J. Hensley, Shilpa Gupta, Hikmat Al-Ahmadie, Marko Babjuk, Peter C. Black, Maurizio Brausi, Kelly K. Bree, Mario I. Fernández, Charles C. Guo, Amir Horowitz, Donald L. Lamm, Seth P. Lerner, Yair Lotan, Paramananthan Mariappan, David McConkey, Laura S. Mertens, Carmen Mir, Jeffrey S. Ross, Michael O’Donnell, and Ashish M. Kamat.
Amir Horowitz, PhD is an Assistant Professor of Oncological Sciences and a member of the Precision Immunology Institute and the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. He pioneered the first studies of human NK cells by mass cytometry (CyTOFTM).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023